Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 11Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 7Lymphoma, Non-Hodgkin 7Multiple Myeloma 6Congenital Abnormalities 6Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Myeloproliferative Disorders 4Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Chronic 3Hematologic Neoplasms 3Graft vs Host Disease 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Recurrence 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Follicular 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Blast Crisis 2

Interventions

Cyclophosphamide 48fludarabine phosphate 45fludarabine 38Whole-Body Irradiation 38Mycophenolic Acid 37Imatinib Mesylate 36nilotinib 34Tacrolimus 30Busulfan 23Cyclosporine 18Melphalan 17Granulocyte Colony-Stimulating Factor 17Dasatinib 17thymoglobulin 16Methotrexate 16Thiotepa 15Peripheral Blood Stem Cell Transplantation 15Antilymphocyte Serum 15bosutinib 13Filgrastim 13Stem Cell Transplantation 11sargramostim 8ponatinib 8Cytarabine 8Cyclosporins 8Cord Blood Stem Cell Transplantation 8Clofarabine 8Sirolimus 7Rituximab 7plerixafor 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Transplantation × Clear all
NCT00003838 2023-09-21

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
202 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00809276 2015-02-16

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
92 enrolled 5 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡